Navigation Links
InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
Date:2/5/2010

d the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of InfoSpi Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

www.infospiinc.com

SOURCE InfoSpi Inc.

RELATED LINKS
http://www.infospiinc.com

'/>"/>

SOURCE InfoSpi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market
2. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Adaptive Trial Paper Explores Benefits of Adaptive Trials for Phase I, Phase II Studies
6. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
7. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
8. Commercial Insurance Buyers Benefit From Ample Capacity
9. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
10. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
11. LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014   Sequenom, Inc. ... company that provides innovative genetic analysis solutions, and ... esoteric laboratory services in the United States ... prenatal testing patents and applications. "We have ... and patient care, and we welcome the opportunity to ...
(Date:7/29/2014)... particle be separated from its properties? On July 29, ... results of the first Cheshire Cat experiment, separating a ... in Orange, CA, and Vienna University of Technology. , ... grin," thought Alice in Wonderland, "but a grin without ... saw in my life!" Alice,s surprise stems from her ...
(Date:7/29/2014)... has created a new way of manufacturing microstructured ... made by self-assembly of carbon nanotubes, could exhibit ... mechanical stiffness and strength, or the ability to ... have demonstrated that mechanical forces can be used ... and that we can independently control the ...
(Date:7/29/2014)... YORK , July 29, 2014  Pomerantz LLP ... Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On July 29, 2014, Impax Laboratories, ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4A new way to make microstructured surfaces 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2
... 14, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... DIEGO, Sept. 14 Stemedica Cell Technologies, Inc., a ... announced today that it has completed its proprietary master ... cell bank was manufactured in accordance with FDA Good ... all the necessary safety testing required by the FDA ...
... Regenicin™, Inc. (OTC Bulletin Board: ... today that John J. Weber, the former highest ranking ... ("Fujifilm USA"), has agreed to join the company as ... Chief Financial Officer.  Weber brings over 20 years of ...
Cached Biology Technology:NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 2NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 3NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 4NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 5NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 6NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 7Stemedica Announces Completion of Clinical Stem Cell Master Bank 2Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO 2
(Date:7/30/2014)... develop into a multitude of cells types. Researchers would like ... types of mature cells that make up the organs and ... to be long chains of sugars that dangle from proteins ... University of California, San Diego, has created synthetic molecules that ... more easily manipulated to direct the process, they report in ...
(Date:7/30/2014)... the journal Scientific Reports , published by ... found that while global temperature is indeed increasing, so ... while each year,s average hottest and coldest temperatures will ... within a wider range of potential high and low ... that even as overall temperatures rise, we may still ...
(Date:7/29/2014)... science, researchers sometimes need to get back to ... that to study the impacts of the bumphead ... ecosystems at two remote locations in the central ... and computer simulation, McCauley, an assistant professor in ... and his colleagues sought to understand whether the ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2Underwater elephants 2Underwater elephants 3
... Dr. Gregory King, professor and chair of the Department ... the recipient of the 2009 Craniofacial Biology Research Award, ... Research (IADR) at its 87th General Session & Exhibition ... King began his undergraduate studies in Biology at Brown ...
... sinks have on rising carbon emissions is gradually weakening, ... grasslands and oceans are absorbing carbon dioxide (CO 2 ... are not keeping pace with rapidly rising emissions," says ... Dr Mike Raupach. "While these natural CO 2 ...
... in Newark and the surrounding area, NJIT has received a ... This grant renews the Foundation,s valuable support ... about nutrition, physical fitness and healthy lifestyles. At NJIT, the ... Education in Greater Newark, a partnership of NJIT, Rutgers University ...
Cached Biology News:Carbon sinks losing the battle with rising emissions 2
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...
Anti-Mouse D011.10 TCR, Biotin (Clone KJ1-26) (mouse IgG2a)...
Reacts with methylated DNA from plants and vertebrates...
Biology Products: